[1] 中国疾病预防控制中心. 全国手足口病监测方案(2014年版)[Z]. 2014. [2] ZHANG Y,ZHU Z,YANG W,et al.An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China[J]. Virol J,2010,7(1):94. [3] SOLOMOM T,LEWTHWAITE P,PERERA D,et al.Virology,epidemiology,pathogenesis,and control of enterovirus 71[J]. Lancet Infect Dis,2010,10(11):778-790. [4] 陈琦,邢学森,吴杨,等. 湖北省2009—2015年手足口病流行病学和病原学分析[J]. 中华流行病学杂志,2017,38(4):441-445. [5] XING W,LIAO Q,VIBOUD C,et al.Hand,foot,and mouth disease in China,2008-12:an epidemiological study[J]. Lancet Infect Dis,2014,14(4):308-318. [6] ANG L W,KOH B K,CHAN K P,et al.Epidemiology and control of hand,foot and mouth disease in Singapore,2001-2007[J]. Ann Acad Med Singapore,2009,38(2):106-112. [7] 李冰,毛辉曙,王萍,等. 江山市手足口病空间聚集性分析[J].预防医学,2018,30(7):707-710. [8] ZHU F C,LIANG Z L,MENG F Y,et al.Retrospective study of the incidence of HFMD and seroepidemiology of antibodies against EV71 and CoxA16 in prenatal women and their infants[J]. PLoS One,2012,7(5):e37206. [9] 中国疾病预防控制中心.肠道病毒71型灭活疫苗使用技术指南[Z]. 2016. [10] LUO K W,GAO L D,HU S X,et al.Hand,foot,and mouth disease in Hunan Province,China,2009-2014[J]. Epidemiology and Death Risk Factors,2016,11(11):e0167269. [11] CHANG L Y,LIN T Y,HSU K H,et al.Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand,foot,and mouth disease[J]. Lancet,1999,354(9191):1682-1686. [12] 赵丹,吴凤彤. 辽阳市手足口病流行特征分析[J]. 预防医学,2019,31(7):722-725. [13] HUANG C C,LIU C C,CHANG Y C,et al.Neurologic complications in children with enterovirus 71 infection[J]. N Engl J Med,1999,341(13):936-942. [14] 郑亚明,常昭瑞,姜黎黎,等. 手足口病重症病例分析:基于全国手足口病监测试点数据[J]. 中华流行病学杂志,2017,38(6):759-762.
